How Variations in Pharmacogenomic Profiles Affect Pain and Narcotic Needs Following Total Knee Arthroplasty (TKA)

NCT04020471 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 375

Last updated 2023-04-27

No results posted yet for this study

Summary

The purpose of the study is to gain a better understanding of how genetic variations can affect pain experience and the need and type of pain control medication after a total knee replacement.

Conditions

Interventions

OTHER

Pain Scale/Medication Log

Daily recording of pain level after surgery and recording of medication taken for pain relief.

Sponsors & Collaborators

  • Endeavor Health

    lead OTHER

Principal Investigators

  • Richard L Wixson, MD · Endeavor Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-11
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04020471 on ClinicalTrials.gov